Evidenced-Based Screening Strategies for a Positive Family History - PubMed

Evidenced-Based Screening Strategies for a Positive Family History - PubMed

Evidenced-Based Screening Strategies for a Positive Family History

Jennifer M Kolb 1, Dennis J Ahnen 2, N Jewel Samadder 3

Affiliations 

• PMID: 32439091
 
• DOI: 10.1016/j.giec.2020.02.015

Abstract

The most commonly recognized high-risk group for colorectal cancer (CRC) is individuals with a positive family history. It is generally recognized that those with a first-degree relative (FDR) with CRC are at a 2-fold or higher risk of CRC or advanced neoplasia. FDRs of patients with advanced adenomas have a similarly increased risk. Accordingly, all major US guidelines recommend starting CRC screening by age 40 in these groups. Barriers to screening this group include patient lack of knowledge on family and polyp history, provider limitations in collecting family history, and insufficient application of guidelines.

Keywords: Advanced adenoma; Colon cancer screening; Colorectal cancer; First-degree relative; Second-degree relative.

Copyright © 2020 Elsevier Inc. All rights reserved.

Conflict of interest statement

Disclosure None.

Similar articles

• Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus.

  Leddin D, Lieberman DA, Tse F, Barkun AN, Abou-Setta AM, Marshall JK, Samadder NJ, Singh H, Telford JJ, Tinmouth J, Wilkinson AN, Leontiadis GI.Gastroenterology. 2018 Nov;155(5):1325-1347.e3. doi: 10.1053/j.gastro.2018.08.017. Epub 2018 Aug 16.PMID: 30121253
• Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study.

  Quintero E, Carrillo M, Leoz ML, Cubiella J, Gargallo C, Lanas A, Bujanda L, Gimeno-García AZ, Hernández-Guerra M, Nicolás-Pérez D, Alonso-Abreu I, Morillas JD, Balaguer F, Muriel A; Oncology Group of the Asociación Española de Gastroenterología (AEG).PLoS Med. 2016 May 3;13(5):e1002008. doi: 10.1371/journal.pmed.1002008. eCollection 2016 May.PMID: 27138769 Free PMC article. Clinical Trial.
• Chemoprevention of colorectal cancer: systematic review and economic evaluation.

  Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320.PMID: 20594533 Review.
• Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah.

  Tuohy TM, Rowe KG, Mineau GP, Pimentel R, Burt RW, Samadder NJ.Cancer. 2014 Jan 1;120(1):35-42. doi: 10.1002/cncr.28227. Epub 2013 Oct 21.PMID: 24150925
• Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.

  Lowery JT, Ahnen DJ, Schroy PC 3rd, Hampel H, Baxter N, Boland CR, Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R.Cancer. 2016 Sep 1;122(17):2633-45. doi: 10.1002/cncr.30080. Epub 2016 Jun 3.PMID: 27258162 Free PMC article. Review.